FDA
approval
· 2017-01-18
FDA Approved: RHOFADE — Original Application (EPI Health, LLC)
Summary
FDA approves Rhofade (oxymetazoline hydrochloride) from EPI Health as an original application for the treatment of persistent facial redness associated with ros…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for RHOFADE (OXYMETAZOLINE HYDROCHLORIDE)